教員業績データベース |
|
論文種別 | 原著 |
言語種別 | 英語 |
査読の有無 | 査読あり |
表題 | Patient satisfaction after sclerotherapy of venous malformations in children |
掲載誌名 | 正式名:Pediatrics international : official journal of the Japan Pediatric Society 略 称:Pediatr Int ISSNコード:1442-200X(Electronic)1328-8067(Linking) |
掲載区分 | 国外 |
巻・号・頁 | 58(8),pp.721-5 |
著者・共著者 | Nakahata Kengo, Uehara Shuichiro, Zenitani Masahiro, Nakamura Masahisa, Osuga Keigo, Okuyama Hiroomi |
発行年月 | 2016/08 |
概要 | BACKGROUND:We have introduced and performed percutaneous sclerotherapy on pediatric patients, and information regarding the mid- and long-term results after percutaneous treatment of peripheral venous malformations is necessary to counsel pBACKGROUND:atients and their parents about the outcome of the therapy. This study was designed to retrospectively evaluate the long-term satisfaction of pediatric patients following percutaneous sclerotherapy for venous malformations (VMs).METHODS:A total of 53 children younger than 16 years of age with VMs who underwent sclerotherapy were included in this study. Self-assessment questionnaires regarding the treatment effectiveness and patients' satisfaction were sent to 50 of 53 patients. Sclerotherapy was performed using 3% polidocanol, absolute ethanol, or 5% ethanolamine oleate (EO).RESULTS:The median numbers of sessions per patient was 2.0 (range, 1-12), and the median follow-up time was 1.8 years (range, 6months-8.3years). Forty-two patients (84%) returned the questionnaire. The most frequent symptom was swelling (95%, 40/42) before sclerotherapy. After treatment, patients felt less pain (82%, 23/28), functional limitation (78%, 14/18), swelling (70%, 28/40), and cosmetic disfigurement (59%, 13/22). None of the patients respondedRESULTS:"RESULTS:worseRESULTS:"RESULTS:for any symptoms, and 30 patients (71%) reported beingRESULTS:"RESULTS:very satisfiedRESULTS:"RESULTS:orRESULTS:"RESULTS:satisfiedRESULTS:"RESULTS:with the treatment.CONCLUSION:Percutaneous sclerotherapy of VMs was safe and effective for relieving symptoms in our pediatric patients, and many of them were satisfied with the outcomes. |
DOI | 10.1111/ped.12880 |
PMID | 26662951 |